BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Deals

  Charles River Laboratories (Massachusetts) And Galapagos NV Complete Transaction

  April 1, 2014

   · 

  1 min read
• Biotech Bay

  ReVance Therapeutics, Inc. Added To Russell 2000® And 3000® Indexes

  April 1, 2014

   · 

  1 min read
• Drug Development

  First Cohort Results In Galectin Therapeutics’ Phase 1 Trial Reveal Biomarker Evidence Of Therapeutic Effect On Fibrosis And Inflammation In Nash With Advanced Fibrosis

  April 1, 2014

   · 

  1 min read
• Business

  Amarin Corporation PLC And Kowa Pharmaceuticals America Announce U.S. Co-Promotion Agreement For Vascepa® (Icosapent Ethyl) Capsules

  April 1, 2014

   · 

  1 min read
• Business

  Celladon Corporation Reports Fourth Quarter and Year-End 2013 Financial Results And Recent Highlights

  April 1, 2014

   · 

  1 min read
• Number Of Shares And Votes In Orexo AB

  April 1, 2014

   · 

  1 min read
• Vernalis PLC: Announcement of Results For Year Ended 31 Dec 2013

  April 1, 2014

   · 

  5 min read
• Genmab A/S’s Total Number Of Voting Rights And Total Share Capital

  April 1, 2014

   · 

  1 min read
• Business

  DBV Technologies Release: Additional Contribution To The Liquidity Agreement With Natixis

  April 1, 2014

   · 

  1 min read
• Business

  Spine Pain Management, Inc. Reports 2013 Financial Results And Corporate Update And Reminds For Conference Call 4:15 EDT Today

  April 1, 2014

   · 

  1 min read